- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome
This study is testing a new medicine called Milvexian for people who have recently had a heart attack or similar heart problem. We want to see if it can prevent future serious heart issues better than existing treatments, with fewer side effects.
For: Acute Coronary SyndromeNetherlands · Latvia · Denmark - Ongoing, recruitingTherapeutic use (Phase IV)
Escalated single Platelet Inhibition for one month plus Direct oral anticoagulation in patients with Atrial fibrillation and acUte coRonary syndrome undergoing percutaneoUS coronary intervention (EPIDAURUS)
This study looks at different ways to treat people who have both an irregular heartbeat (atrial fibrillation) and have recently had a heart attack. It compares how well different medicines prevent further heart problems like strokes, while also checking for any serious bleeding.
Austria · Germany